East-West United Bank SA v Gusinski & Ors - Civil Conspiracy Pleading Amendment

The England and Wales High Court granted East-West United Bank SA leave to amend its civil conspiracy pleadings. Mr Justice Rajah rejected the defendants' objection that the proposed amendment (adding paragraph 98(0A)) disclosing joinder to the conspiracy by January 2018 lacked prospects of success. The court found the amendment fell within the scope of what was already pleaded and that concerted action need not be proven for parties to have joined a conspiracy.

CYK v Kent County Council - Judicial Review of Leaving Care Provisions for Asylum Seekers

The England and Wales High Court ruled in judicial review proceedings that Kent County Council's refusal to provide leaving care support to asylum-seeking qualifying young persons under s 24A(5) of the Children Act 1989 was unlawful. The court confirmed the interpretation established in R (AAM) v Bromley London Borough Council regarding the interrelationship between local authority leaving care functions and the Secretary of State's asylum support obligations. This binding precedent affects local authorities' duties to asylum-seeking care leavers.

Cabo Concepts v MGA Entertainment - Intellectual Property Sanctions

The England and Wales High Court (Chancery Division) issued a judgment on 31 March 2026 in Cabo Concepts Ltd v MGA Entertainment, addressing MGA's sanctions application regarding Cabo's alleged breaches of disclosure obligations and inaccurate evidence. The court reviewed the previously ordered indemnity costs (GBP 578,444.17 interim payment) arising from MGA's own 2022 disclosure failures that caused a trial adjournment. Mrs Justice Bacon delivered the judgment following a hearing on 29-30 January 2026.

A Mother v A Father - Parental Alienation Appeal

The England and Wales High Court (Family Division) dismissed a mother's appeal against findings that she fabricated abuse allegations against the father and engaged in parental alienation of twin children P and Q. Mr Justice Poole upheld the lower court's application of the three-stage Family Justice Council Guidance (December 2024) in reaching parental alienation findings. The appeal on grounds of procedural unfairness and insufficient reasons was rejected.

Banksy copyright case against Brandalised, ruling 1st Apr

Banksy copyright case against Brandalised, ruling 1st Apr

Chromogranin A immunoassay for neuroendocrine tumour and prostate cancer diagnosis

The European Patent Office published patent application EP3633378A1 by Cézanne S.A.S. covering a Chromogranin A immunoassay for diagnosis, risk assessment, risk stratification, therapy control, and post-operative control of neuroendocrine tumours or prostate cancer. The application was published March 25, 2026 with designated states covering all EU member states plus additional European countries.

Methods and Means for the Production of Ig-like Molecules

European Patent Office published patent application EP3594233A1 for Merus B.V. covering methods and means for producing Ig-like molecules. The patent was published on March 25, 2026, with inventors de Kruif, Hendriks, and Logtenberg, and designates all EU member states plus Switzerland, Norway, and other European countries.

Ig-like molecules production patent

The European Patent Office published patent application EP3594232A1 for Merus B.V., covering methods and means for production of Ig-like molecules. The application was filed by inventors de Kruif, Hendriks, and Logtenberg, with publication date March 25, 2026. Designated states include all EU member states plus Switzerland, Norway, and other EPC contracting states.

Alzheimer's Treatment Patent - Pooled Immunoglobulin G

The European Patent Office published patent application EP3552624A1 for Takeda Pharmaceutical Company Limited, covering a method of treating Alzheimer's disease subpopulations using pooled immunoglobulin G. The patent names five inventors and includes designations for all 31 EPO member states plus extension states.

Merus antibodies modulate cell biological activity, EP3649156A1

Merus antibodies modulate cell biological activity, EP3649156A1